Posted on Jun 18, 2019

Schematic Engineering Industries

The European Pharmacopoeia prescribes light protection for more than 250 drugs and adjuvants across the Pharmaceutical Industry . These light sensitive formulated products may therefore degrade during manufacturing, storage and batch processing leading to a whole host of undesirable consequences.

This light degradation may result in loss of drug potency, altered efficacy and adverse biological effects. For example, Ultraviolet light can cause oxidation, hydrolysis and loss of potency to sensitive medicine solutions.

To reduce and/or eliminate this degradation risk, Schematic Engineering Industries provides barrier isolators with lighting solutions to suit the customer requirements.

An example of which is shown: a Barrier Isolator with Monochromatic Light. Contact Schematic Engineering Industries for further information or press the attached link to the Standard Group of Companies website
Get quote
Message sent. We'll get back to you soon.